07:00 , Mar 30, 2009 |  BC Week In Review  |  Company News

Abeille, ProStrakan deal

ProStrakan received exclusive, worldwide rights excluding certain Asian territories to develop, commercialize and sub-license Abeille's AB-1001 . The transdermal granisetron patch has completed Phase I trials to treat chemotherapy-induced nausea and vomiting (CINV). ProStrakan said...
07:00 , Aug 4, 2008 |  BC Week In Review  |  Clinical News

SyB D-0701: Phase I completed

SymBio completed a pair of Japanese Phase I trials. The company has exclusive rights to SyB D-0701 in Japan and other East Asian countries from Abeille, which is developing it as AB-1001. Abeille Pharmaceuticals Inc....
08:00 , Jan 8, 2007 |  BioCentury  |  Finance

Late stage milestones

Late stage milestones...
07:00 , Aug 14, 2006 |  BC Week In Review  |  Clinical News

AB-1001: Phase III start

Abeille will begin a double-blind, international Phase III study in an undisclosed number patients by year end. Abeille Pharmaceuticals Inc. , Princeton, N.J.   Product: AB-1001   Business: Gastrointestinal   Molecular target: Serotonin (5-HT3) receptor...
07:00 , May 8, 2006 |  BC Week In Review  |  Company News

Abeille, NexMed deal

NEXM granted Abeille an exclusive worldwide license to use NexACT delivery technology for transdermal patch applications. Further terms were not disclosed. Abeille Pharmaceuticals Inc. , Princeton, N.J.   NexMed Inc. (NEXM), East Windsor, N.J.  ...
08:00 , Feb 6, 2006 |  BC Week In Review  |  Clinical News

AB-1001: Phase I start

Abeille started an open-label, 3-month, 3-way crossover, U.S. Phase I trial in 12 healthy volunteers to compare 2 doses of AB-1001 patch with IV administration of the product. Abeille Pharmaceuticals Inc. , Princeton, N.J.  ...
08:00 , Nov 21, 2005 |  BC Week In Review  |  Company News

Abeille scientific advisory board update

Abeille Pharmaceuticals Inc. , Princeton, N.J.   Business: Drug delivery   Appointed: John Babish, SVP of Ashni Naturaceuticals Inc. ; Douglas Flanagan, professor of pharmaceutics at the University of Iowa; Om Ganda, associate clinical professor...
07:00 , Jun 6, 2005 |  BC Week In Review  |  Company News

Abeille board of directors update

Abeille Pharmaceuticals Inc. , Princeton, N.J.   Business: Drug delivery   Appointed: Zsolt Lavotha, president and CEO of Orexo AB; and James Warren, former CEO of Banner Pharmcaps Inc.  ...